Visikol CEO Michael Johnson Named to NJBIZ 2021 Next Generation of Leaders
On Tuesday, Visikol's CEO Michael Johnson was named to the 2021 Next Generation of Leaders List by NJBIZ. The [...]
Clinical Implications of Multiplex Imaging
In 2021, over 1,000,000 new cases of cancer and over 600,000 cancer deaths are projected to occur in the [...]
Sandwich ELISA: An Endpoint for Biological Studies
ELISA (Enzyme Linked Immunosorbent Assay) is a well-established analytical biochemical assay that is used to detect the presence of an antigen (analyte or ligand). The purpose of the [...]
Nuclear Staining: Overview of Hematoxylin
In histology, staining is the method used to identify regions, counts or other structural features of a cell. Nuclear stains are used for the staining of [...]
Visikol Goes Carbon Neutral!
Mike Johnson2021-07-09T15:03:11-05:00Effective today, Visikol has become and is committed to remain a carbon neutral company. While Visikol is a leading [...]
Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services
TUE, JUL 06, 2021 15:00 CET Over the last two months, both MatTek and Visikol have been acquired by [...]
Visikol expands its Hampton, NJ Facility
Visikol has announced today another expansion of its Hampton, NJ facility. Through the expansion, Visikol has grown its lab [...]
Stop Calling Everything an Organoid! – 3D Cell Culture Terminology
As a company focused on 3D cell culture models and assays, we routinely have researchers ask us about organoid [...]
Liver Steatosis: 2D and 3D Screening Platforms
Steatosis is characterized by abnormal retention of lipids within an organ and is most common within the liver due to [...]
Visikol Launches DILI 3D Cell Culture Assay Services Using Corning® Qualified 3D PHH Spheroid Assay-Ready Plates
Mike Johnson2021-05-28T08:08:34-05:00Over the last few years, researchers have begun to transition from using traditional two-dimensional cell culture models for assessing [...]